Page 1

For personal use only Name of entity Botanix Pharmaceuticals Limited ABN 70 009 109 755 For announcement to the market Appendix 4E Final report , .Rules 4.3A Financial year ended ( ' current period ' ) 30 June 2021 ( ' comparative period ' ) 30 June 2020 $ AUD Other income from continuing operations Down 36.8 % to 114,038 Loss from ordinary activities after tax attributable to members Down 80.1 % to ( 3,334,001 ) Net loss for the period attributable to members Down 79.6 % to ( 3,405,015 ) Dividends ( distributions ) Interim dividend Final dividend Previous corresponding period * Record date for determining entitlements to the dividend , ( in the case of a trust , distribution ) Amount per security Franked amount per security Nil - C Nil - ¢ Nil - ¢ N / A Net Tangible Assets per share 30 June 2021 30 June 2020 Net tangible asset backing per ordinary security ( cents per 2.14 2.43 share ) The above results should be read in conjunction with the notes and commentary contained in the Annual Report lodged with this report .